Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products;... Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments. The Life Science Services and Products segment provide research services and products which are used in fundamental to life-science research and application. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. It also offers SurePAGE, a precast gel series; CytoSinct, a Nanobeads product and services; and Benz-Neburase, a genetically engineered endonuclease. In addition, the company provides automated protein and antibody purification system; automated maxi-plasmid purification; automated mini-scale purification for plasmid, protein, and antibody; eBlot and eStain, a protein transfer and staining system; eZwest Lite, an automated western blotting device; CytoSinct, a cell isolation solution; pharmacokinetics and immunogenicity ELISA kits; COVID-19 detection cPass technology kits; and GenBox, a mini electrophoresis tank. It serves antibody drug discovery; gene therapy; vaccine; in vitro diagnostics; gene editing; plant biology; and synthetic biology solutions. The company was founded in 2002 and is headquartered in Wan Chai, Hong Kong. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.5 | 1.5 | 1.5 | 300 | 1.5 | CS |
| 4 | 0 | 0 | 1.5 | 1.5 | 1.5 | 300 | 1.5 | CS |
| 12 | 0.08 | 5.6338028169 | 1.42 | 1.9 | 1.42 | 304 | 1.66185876 | CS |
| 26 | -0.34 | -18.4782608696 | 1.84 | 1.9 | 1.3 | 5294 | 1.56178431 | CS |
| 52 | -0.17 | -10.1796407186 | 1.67 | 2.42 | 1.3 | 3749 | 1.75460354 | CS |
| 156 | -0.65 | -30.2325581395 | 2.15 | 3.2 | 1.05 | 14545 | 1.54921602 | CS |
| 260 | -3.3 | -68.75 | 4.8 | 5.3 | 1.05 | 9024 | 2.10105376 | CS |
Kjv
6分前
JDerb
6分前
Wizzerd
6分前
valuemind
7分前
Kjv
7分前
stoxjock
7分前
Michael Weston
8分前
boston127
9分前
jman4956
10分前
Michael Weston
12分前
gdog
18分前
rbb
19分前
Soog
20分前
boston127
20分前
art2426
20分前
Wizzerd
21分前
Rocky3
25分前
Wizzerd
25分前
Kjv
27分前
FrostyIsland3
27分前
Renorocker
29分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。